neoplasm
• mice transplanted subcutaneously with PDVC57 mouse skin squamous carcinoma cells show delayed onset of tumor formation compared to wild-type mice, resulting in decelerated growth and reduced numbers of skin tumors
|
• mice treated with DMBA/TPA to induce tumorigenesis show a delay in onset of tumors compared to wild-type mice
• DMBA/TPA induced-tumors are mostly papillomas whereas wild-type tumors progress to squamous cell carcinomas
|
immune system
• DMBA/TPA-induced papillomas show suppressed expression of inflammatory cytokines, including Tslp, Il-17, Il-23, Il-1b, and Tnf-alpha
• PDVC57 tumors show reduced expression of Il-1b, Il-17, and Tnf-alpha
|
• tumors from DMBA/TPA-induced mice show decreased numbers of infiltrating macrophages, polymorphonuclear cells, and lymphocytes compared to wild-type mice
|
• mice exhibit suppressed TPA-induced skin inflammation compared to wild-type mice, showing decreased expression of cytokines Tnf-alpha, Tslp, IL-1b, Il-17, Il-18, and Il-23 and reduced thickness of the epidermis
|
homeostasis/metabolism
• DMBA/TPA-induced papillomas show suppressed expression of inflammatory cytokines, including Tslp, Il-17, Il-23, Il-1b, and Tnf-alpha
• PDVC57 tumors show reduced expression of Il-1b, Il-17, and Tnf-alpha
|
• mice treated with DMBA/TPA to induce tumorigenesis show a delay in onset of tumors compared to wild-type mice
• DMBA/TPA induced-tumors are mostly papillomas whereas wild-type tumors progress to squamous cell carcinomas
|
integument
• hypoproliferative epidermis
• however, epidermis shows normal differentiation patterns and whiskers appear normal
|
• mice exhibit suppressed TPA-induced skin inflammation compared to wild-type mice, showing decreased expression of cytokines Tnf-alpha, Tslp, IL-1b, Il-17, Il-18, and Il-23 and reduced thickness of the epidermis
|